These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29783485)

  • 1. Individualization of leflunomide dosing in rheumatoid arthritis patients.
    Hopkins AM; O'Doherty CE; Foster DJ; Upton RN; Proudman SM; Wiese MD
    Per Med; 2014 Jun; 11(4):449-461. PubMed ID: 29783485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model.
    Bae J; Park JW
    Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of teriflunomide: do plasma concentrations predict response to leflunomide in patients with rheumatoid arthritis?
    Rawdha T; Aicha BT; Lobna BA; Issam S; Mouna BS; Olfa S; Selma B; Takoua BB; Kawther BA; Leila M; Hana S; Ines M; Leila A
    Drug Metab Pers Ther; 2023 Mar; 38(1):79-85. PubMed ID: 35998916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis.
    Hopkins AM; Wiese MD; Proudman SM; O'Doherty CE; Upton RN; Foster DJ
    Br J Clin Pharmacol; 2016 Jan; 81(1):113-23. PubMed ID: 26331989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide Concentration.
    Hopkins AM; Moghaddami M; Foster DJ; Proudman SM; Upton RN; Wiese MD
    Drug Metab Dispos; 2017 Jan; 45(1):8-16. PubMed ID: 27742727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: a pharmacokinetic and pharmacogenetic study.
    Russo PA; Wiese MD; Smith MD; Ahern MJ; Barbara JA; Shanahan EM
    Ann Pharmacother; 2013 Mar; 47(3):e15. PubMed ID: 23447478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients.
    Hopkins AM; Wiese MD; Proudman SM; O'Doherty CE; Foster D; Upton RN
    CPT Pharmacometrics Syst Pharmacol; 2015 Jun; 4(6):362-71. PubMed ID: 26225264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Diarrhea Associated with High Teriflunomide Blood Concentration.
    Duquette A; Frenette AJ; Doré M
    Rheumatol Ther; 2016 Jun; 3(1):179-185. PubMed ID: 27747512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
    Fragoso YD; Brooks JB
    Expert Rev Clin Pharmacol; 2015 May; 8(3):315-20. PubMed ID: 25712857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM
    Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety evaluation of leflunomide in rheumatoid arthritis.
    Keen HI; Conaghan PG; Tett SE
    Expert Opin Drug Saf; 2013 Jul; 12(4):581-8. PubMed ID: 23668332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide: an immunosuppressive drug with multiple effects on T cell function.
    Dimitrova P; Kalden JR; Schulze-Koops H
    Mod Rheumatol; 2002 Sep; 12(3):195-200. PubMed ID: 24387057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
    Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
    BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MS.
    Rakhila H; Rozek T; Hopkins A; Proudman S; Cleland L; James M; Wiese M
    J Pharm Biomed Anal; 2011 May; 55(2):325-31. PubMed ID: 21349677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of leflunomide.
    Rozman B
    Clin Pharmacokinet; 2002; 41(6):421-30. PubMed ID: 12074690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the interactions of leflunomide and teriflunomide within receptor cavity--NMR studies and energy calculations.
    Kujawski J; Bernard MK; Jodłowska E; Czaja K; Drabińska B
    J Mol Model; 2015 May; 21(5):105. PubMed ID: 25851105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea.
    Schläpfer E; Fischer M; Ott P; Speck RF
    AIDS; 2003 Jul; 17(11):1613-20. PubMed ID: 12853743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis.
    Reddy SV; Wanchu A; Khullar M; Govindrajan S; Bambery P
    Int Immunopharmacol; 2005 Jun; 5(6):1085-90. PubMed ID: 15829424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.